Company: FLYE
Filing Date: 2025-07-15
Form Type: 10-K
Source: 0001213900-25-064293
Chunk: 204

Company: Fly-E Group, Inc.
Filing Date: 2025-07-15
Form: 10-K
Item: Item 1A
Chunk 204
---
iations in
                                            our financial results or the financial results of companies that are perceived to be similar
                                            to us;

●sales of common
                                            stock by us, our executive officers, directors or principal stockholders or others;

●general economic,
                                            industry and market conditions, such as the impact of the COVID-19 pandemic on our industry;

27

●the publication
                                            of unfavorable research reports and updates thereto by financial analysts; and

●the other factors
                                            described in this “Risk Factors” section.

In the past, many companies
that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be
the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert our
management’s attention from other business concerns, which could seriously harm our business.

We incur increased costs as a result of
being a publicly traded company.

As a company with publicly traded securities,
we incur additional legal, accounting and other expenses not presently incurred. In addition, the Sarbanes-Oxley Act of 2002, the Dodd-Frank
Wall Street Reform and Consumer Protection Act of 2010, as well as rules promulgated by the SEC and the national securities exchange
on which we list, requires us to adopt corporate governance practices applicable to U.S. public companies. These rules and regulations
will increase our legal and financial compliance costs.

If securities or industry analysts do not
publish research or reports about us, or if they adversely change their recommendations regarding our common stock, then our stock price
and trading volume could decline.

The trading market for our common stock will
be influenced by the research and reports that industry or securities analysts publish about us, our industry and our market. If no analyst
elects to cover us and publish research or reports about us, the market for our common stock could be severely limited and our stock
price could be adversely affected. As a small-cap company, we are more likely than our larger competitors to lack coverage from securities
analysts. In addition, even if we receive analyst coverage, if one or more analysts ceases coverage of us or fails to regularly publish
reports on us, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline.
If one or more analysts who elect to cover us issue negative reports or adversely change their recommendations regarding our common stock,
our stock price could decline.

We are an “emerging